Meridian Medical Technologies, LLC A Subsidiary Of Kindeva Drug Delivery, L.P. FDA Record
- Latest inspection VAI · Jun 30, 2026
- Last warning letter 2017
Meridian Medical Technologies, LLC A Subsidiary Of Kindeva Drug Delivery, L.P. has 0 FDA recalls, 19 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Meridian Medical Technologies, LLC A Subsidiary Of Kindeva Drug Delivery, L.P., the most recent on Sep 5, 2017.
- Latest inspection
- Jun 30, 2026 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 19 | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Meridian Medical Technologies, LLC A Subsidiary Of Kindeva Drug Delivery, L.P.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 1 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 1 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 1 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 1 | 1 | 1 | 0 | 0 |
Reviewing Meridian Medical Technologies, LLC A Subsidiary Of Kindeva Drug Delivery, L.P. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Meridian Medical Technologies, LLC A Subsidiary Of Kindeva Drug Delivery, L.P. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Meridian Medical Technologies, LLC A Subsidiary Of Kindeva Drug Delivery, L.P. FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Sep 5, 2017 · Record page |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Jun 30, 2026 | Saint Louis, MO | Drugs | Voluntary Action Indicated (VAI) | 1950222 |
| Jun 5, 2024 | Saint Louis, MO | Drugs | Voluntary Action Indicated (VAI) | 1950222 |
| Dec 21, 2019 | Saint Louis, MO | Devices | No Action Indicated (NAI) | 1950222 |
| Mar 24, 2017 | Saint Louis, MO | Devices | Official Action Indicated (OAI) | 1950222 |
| Mar 23, 2015 | Saint Louis, MO | Drugs | Voluntary Action Indicated (VAI) | 1950222 |
| Nov 25, 2014 | Saint Louis, MO | Drugs | Official Action Indicated (OAI) | 1950222 |
| Feb 21, 2014 | Saint Louis, MO | Devices | Official Action Indicated (OAI) | 1950222 |
| Feb 21, 2014 | Saint Louis, MO | Drugs | Official Action Indicated (OAI) | 1950222 |
| Oct 9, 2013 | Saint Louis, MO | Drugs | Official Action Indicated (OAI) | 1950222 |
| Oct 9, 2013 | Saint Louis, MO | Drugs | Official Action Indicated (OAI) | 1950222 |
| Apr 29, 2013 | Saint Louis, MO | Drugs | Official Action Indicated (OAI) | 1950222 |
| Mar 4, 2013 | Saint Louis, MO | Devices | No Action Indicated (NAI) | 1950222 |
| Feb 13, 2012 | Saint Louis, MO | Drugs | Voluntary Action Indicated (VAI) | 1950222 |
| Feb 13, 2012 | Saint Louis, MO | Drugs | Voluntary Action Indicated (VAI) | 1950222 |
| May 12, 2011 | Saint Louis, MO | Drugs | No Action Indicated (NAI) | 1950222 |
| Aug 18, 2010 | Saint Louis, MO | Drugs | Voluntary Action Indicated (VAI) | 1950222 |
| Aug 18, 2010 | Saint Louis, MO | Drugs | Voluntary Action Indicated (VAI) | 1950222 |
| Jul 31, 2009 | Saint Louis, MO | Drugs | Voluntary Action Indicated (VAI) | 1950222 |
| Jul 31, 2009 | Saint Louis, MO | Drugs | Voluntary Action Indicated (VAI) | 1950222 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under Meridian Medical Technologies, LLC A Subsidiary Of Kindeva Drug Delivery, L.P.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 1950222 | Saint Louis, MO | 19 | Jun 30, 2026 |
Meridian Medical Technologies, LLC A Subsidiary Of Kindeva Drug Delivery, L.P. and the FDA: common questions
Has Meridian Medical Technologies, LLC A Subsidiary Of Kindeva Drug Delivery, L.P. received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Meridian Medical Technologies, LLC A Subsidiary Of Kindeva Drug Delivery, L.P.. The most recent is dated Sep 5, 2017.
Has Meridian Medical Technologies, LLC A Subsidiary Of Kindeva Drug Delivery, L.P. received an FDA Form 483?
FDA has not published a Form 483 for "Meridian Medical Technologies, LLC A Subsidiary Of Kindeva Drug Delivery, L.P." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Meridian Medical Technologies, LLC A Subsidiary Of Kindeva Drug Delivery, L.P.?
The most recent FDA inspection on file ended Jun 30, 2026 at Saint Louis, MO and was classified VAI. FDA has 19 inspections of Meridian Medical Technologies, LLC A Subsidiary Of Kindeva Drug Delivery, L.P. on file, 7 of them classified OAI (official action indicated).
Need more than this page shows? Ask about Meridian Medical Technologies, LLC A Subsidiary Of Kindeva Drug Delivery, L.P. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.